Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

NCT05092412 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Extensive-stage Small-cell Lung Cancer
Durvalumab

Interventions

RADIATION: Low-dose radiotherapy
DRUG: Durvalumab
DRUG: Etoposide, and cisplatin/carboplatin

Sponsor

You Lu

Collaborators

[object Object]